CONFERENCE SCHEDULE

WEDNESDAY,  SEPTEMBER 8, 2021 - GENERAL LIFE SCIENCE DAY

All times are in Eastern Time Zone - USA

9:00am // OPENING REMARKS

9:10am // KEYNOTE SPEAKER - Dennis Purcell, Founder Aisling Capital, Life Sciences. Topic: Where do we go from here?

9:40am // Corporate Presentation - Pixel Technology

10:00 am // Corporate Presentation - Patia

10:20 am // Corporate Presentation - Cipher Surgical

10:40 am // Corporate Presentation -  VitalTech

11:00 am // Corporate Presentation - Tactical Therapeutics

11:20 am // Corporate Presentation - Imaginostics

11:40 am // Corporate Presentation -  Feldan Therapeutics

12:00 pm // Corporate Presentation - Intrommune Therapeutics

12:20 pm // Corporate Presentation - Entac Medical

12:40 pm // Corporate Presentation - LifeOmic

1:00 pm // SPEAKER - Chris Apfel,  Chair, Keiretsu Forum Life Sciences | CEO, SageMedic.  Topic: Sage Advice for Investors: How to Pick Winners in Life Sciences

1:30 pm // Corporate Presentation - Travel Telemed

1:50 pm // Corporate Presentation - True Digital Surgery

2:10 pm // Corporate Presentation - Spine Thera

2:30 pm // Corporate Presentation - Taiga Biotechnologies

2:50 pm // Corporate Presentation - Tetra Biopharma

3:10 pm // Corporate Presentation - NanoView Biosciences

3:30 pm // Corporate Presentation - Thrive Bioscience

3:50 pm // Corporate Presentation - AseptiScope

4:10 pm // Corporate Presentation - Biovista

4:30 pm // Corporate Presentation - SageMedic

4:50 pm // SPEAKER - Alfred Slanetz, CEO, Geneius |Former CEO, Bluebird Bio | Former Director Product Development, Genetech.  Topic: T-cell Therapies for Cancer

5:30 pm // CLOSING REMARKS

THURSDAY, SEPTEMBER 9, 2021 - NEUROLOGY DAY

All times are in Eastern Time Zone - USA

9:00am // OPENING REMARKS

9:10am // KEYNOTE SPEAKER - Rakesh Jain, Andrew Werk Cook Professor of Tumor Biology, Massachusetts General Hospital in the Harvard Medical School | Director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts General Hospital.  Topic: Improving Treatment of Primary and Metastatic Brain Tumors

9:50am // SPEAKERS - Susan Ano, Tech Transfer Director, National Institute of Neurological Disorders and Stroke/NHI. Jenny Wong, Tech Transfer Director, National Institute of Mental Health/NHI. Topic: Tech Transfers within the National Institute of Health

10:20 am // Corporate Presentation - Biorchestra

10:40 am // Corporate Presentation - Herantis Pharma

11:00 am // Corporate Presentation - MitoImmune Therapeutics

11:20 am // Corporate Presentation - STALICLA

11:40 am // Corporate Presentation - Sinntaxis

12:00 pm // Corporate Presentation - NeuroGeneces

12:20 pm // Corporate Presentation - Neurovine

12:40 pm // Corporate Presentation - Epivario

1:00 pm // SPEAKER - Fred Nazem, Former CEO/Chair, Oxford Health | CEO, Rejuvenan.  Topic: The Silent and Growing Pandemic of Parkinson’s and Neurodegenerative Diseases

1:30 pm // Corporate Presentation - TTM Therapeutics

1:50 pm // Corporate Presentation - Healium

2:10 pm // Corporate Presentation - Lief Therapeutics

2:30 pm // Corporate Presentation - StimScience

2:50 pm // Corporate Presentation - SCYiBL

3:10 pm // Corporate Presentation - Cerevance

3:30 pm // Corporate Presentation - Cognoptix

3:50 pm // Corporate Presentation - Emtensor

4:10 pm // Corporate Presentation - NeuroDex

4:30 pm // Corporate Presentation - Celero Systems

4:50 pm // Corporate Presentation - De Oro Devices

5:10 pm // Corporate Presentation - Kinoxis Therapeutics

5:30 pm // SPEAKER - Francesca Bosetti, Stroke Program Director, National Institute of Neurological Disorders and Stroke/NHI. Topic: Neuroprotection in ischemic stroke: the past, the present and the future

5:50 pm // PANEL DISCUSSION - Moderator: Varun Renjen, Associate Principal, Blue Matter Consulting. Henri Sant Cassia, Co-founder and Managing Partner, The Conscious Fund, Doug Drysdale, CEO, Cybin Pharmaceuticals. Jim Kuo, CEO, Return Health. Olivia Mannix, Founder, Chief Strategy Officer, Aphrodite Health. Suran Goonatilake, Co-Founder April 19 Discovery Inc. Topic: Renaissance of Psychedelics in CNS medicine

6:30 pm // CLOSING REMARKS